Grifols SA Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

A sample of Grifols SA Insights data

Headline Published Journalists
Showing 3 of 8 results. Subscribe to unlock more.
Deserunt mollit sunt Lorem laborum do id aliqua dolore 29 Jan 2021 Lorem
hIVIG trials to hurt from convalescent plasma use in COVID-19; manufacturing limitations to likely present hurdles, experts say 28 Oct 2020 Manasi Vaidya
hIVIG efforts likely to outdo convalescent plasma in COVID-19, but efficacy magnitude unclear with background use of Gilead’s Veklury, experts say 27 Oct 2020 Manasi Vaidya
Emergent BioSolutions planning Phase II/III trial with NIH in 2020 testing hIVIG in early COVID-19, exec says 26 Oct 2020 Manasi Vaidya


Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.


Drug Insights:

  • Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
  • Material intelligence on competitors, including breaking news
  • Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships


Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.


Access more premium companies when you subscribe to Explorer